|Articles|November 6, 2009

Psychiatric Times Vol 26 No 11
Volume 26
Issue 11

November 2009 Table of Contents

NEWS

Mental Health Professionals in the “Enhanced” Interrogation RoomTwitter and YouTube: Unexpected Consequences of the Self-Esteem

EDITORIAL

Doctor: Are You “Drugging” or “Medicating” Your Patients?

PSYCHIATRIC ETHICS

Living the Questions: Cases in Psychiatric Ethics Coming Soon

MOLECULES OF THE MIND

The Cellular and Molecular Substrates of Anorexia Nervosa, Part 1

COMMENTARY

Advice to DSM-V: Integrate with ICD-11The Ethical Policies and Involvement in Enhanced Interrogations of US Psychologists After 9/11

WASHINGTON REPORT

What “Meaningful Use” of Electronic Health Records May Mean to Psychiatrists

POETRY OF THE TIMES

Medical Education

CLINICAL

Depression During Pregnancy

Articles in this issue

almost 16 years ago

Article

Depression During Pregnancy

almost 16 years ago

Article

Living the Questions: Cases in Psychiatric Ethics

almost 16 years ago

Article

What “Meaningful Use” of Electronic Health Records May Mean to Psychiatrists

almost 16 years ago

Article

Medical Education

almost 16 years ago

Article

Current Clinical Practice in Asperger Disorder

almost 16 years ago

Article

The Cellular and Molecular Substrates of Anorexia Nervosa, Part 1

almost 16 years ago

Article

The Ethical Policies and Involvement in Enhanced Interrogations of US Psychologists After 9/11

almost 16 years ago

Article

Tarasoff Redux

almost 16 years ago

Article

The Case of Factitious Disorder Versus Malingering

almost 16 years ago

Article

Firearms and Mental Illness

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe Now!

Latest CME

Case-based Simulation

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Nicholas Doher, DO; Babak Tousi, MD

Multimedia

Community Practice Connections™: Optimizing the Management of Tardive Dyskinesia—Addressing the Complexity of Care With Targeted Treatment

Ilan Melnick, MD; Alejandro Alva, MD; Linda Trinh, DNP, PMHNP, FNP, MPH

Video

PER Psych Summit: Integrating Shared Decision-Making Into Management Plans for Patients With Schizophrenia

Sanjai Rao, MD, DFAPA; Dawn I. Velligan, PhD

In-Person Event

Southern Florida Psychiatry Conference

November 21-22, 2025

In-Person + Virtual Event

Real Psychiatry 2026

January 23-24, 2026

Video

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

Michael Asbach, DMSc, PA-C; Erin Crown, MHS, PA-C, Psych-CAQ

Video

Optimizing Care for Patients With Tardive Dyskinesia

Amber Hoberg, MSN, APRN, PMHNP-BC; Erin Crown, PA-C, Psych-CAQ

Video

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Jonathan Meyer, MD; Jacob Hanaie, PharmD, APh, BCPP; Sanjai Rao, MD, DFAPA

Video

(CME Track) Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

(CME Track) Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Video

(Pharmacist Track) Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

(Pharmacist Track) Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

November 2009 Table of Contents

Articles in this issue

Newsletter

Latest CME

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Community Practice Connections™: Optimizing the Management of Tardive Dyskinesia—Addressing the Complexity of Care With Targeted Treatment

PER Psych Summit: Integrating Shared Decision-Making Into Management Plans for Patients With Schizophrenia

Southern Florida Psychiatry Conference

Real Psychiatry 2026

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

Optimizing Care for Patients With Tardive Dyskinesia

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

(CME Track) Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

(CME Track) Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

(Pharmacist Track) Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

(Pharmacist Track) Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Trending on Psychiatric Times

Evidence-Based Psychotherapy and Psychopharmacology for Mood Disorders: A Conversation With Holly A. Swartz, MD

Can the Initial Antipsychotic Influence Years of Weight Gain?

New Post-Hoc Analysis: Ingrezza 40 mg Leads to Clinically Meaningful Improvements in Tardive Dyskinesia Symptoms

How to Approach Conversations With Adult Patients Who Might Have ADHD: New Tools and Insights

Loneliness, Meet Solitude